Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL-1 receptor antagonist in non-ST elevation acute coronary syndromes
ISRCTN89369318Phase 2Completed
- Sponsor
- University of Sheffield
- Start
- Jan 2007
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
01
Overview
Phase 2, randomised trial in non–ST-segment elevation acute coronary syndrome (NSTE-ACS) comparing Anakinra with Placebo (2 arms). Primary endpoint: Area under the curve of serum high sensitivity C-reactive protein over the first seven days. Started Jan 2007; status: completed.
02
Drugs
anakinra
03
Conditions
non–ST-segment elevation acute coronary syndrome (NSTE-ACS)
Beyond the preview
Go deeper on ISRCTN89369318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN89369318.